Event content

Rapid and efficient development of drug candidates is increasingly important for pharmaceutical companies with accelerated timelines and funding constraints. However, many early drug candidates have poor oral absorption properties making it challenging to achieve target pharmacokinetic (PK) profiles. Witho...

As we bring in 2023, pharmaceutical companies will undoubtedly be looking ahead. But how will the events of the past two COVID years influence future aspirations? In the past, pharmaceutical companies used a mix of bottom-up and top-down processes to budget for the next fiscal year, and then made quarterly...

With the industry digitally evolving, you and your team need to keep up and not be left behind. Join and take part in our panel and learn how to equip and prepare yourself with the latest digital tools in pharma: • Assessing what resources and training services are available • Introducing practical...

• GUCY2C is a mucosally-restricted, immunologically compartmentalized self-antigen overexpressed in GI adenocarcinomas • GUCY2C Vaccination in MRD (minimal residual disease) setting for recurrence prevention • GUCY2C adoptive cell therapy for treatment of metastatic GI cancers

In recent years there are several market trends which are influencing the design of drug delivery devices. The shift to patient care outside the traditional healthcare setting, accelerated by the pandemic, has led to an increase in patient self- treatment. This has also resulted in the need for connected d...

In 2022, the final recommendations of the Product Quality Research Institute were published for Parenteral Drug Products. Apart from the wealth of information and considerations on design of extractable & leachable studies for parenteral drug products in general, it also contains valuable information on sp...

Sub-optimal adherence and persistence to treatment continue to be significant challenges for both on-market drugs and investigational products in clinical development. This is especially true for self-administered medications for chronic disease patients, hence driving the need for improved treatment intak...

More than 75 % of new chemical entities are poorly soluble and require bioavailability-enhancing excipients. The application of excipients in advanced pharmaceutical processes, such as hot melt extrusion and 3D-printing, aligned with advanced approaches towards personalized medicine, requires special featu...

The pipeline for advanced genetic therapies has grown exponentially since 2014, and now totals over 3,500 different developmental candidates. This session provides a comprehensive global snapshot of this R&D landscape, spanning gene, cell, and RNA-based drug modalities. This includes analysis of drug pipel...

Bringing It Home: The New Generation of Clinical Trials


Click here to register

EXCiPACT is extending its certification scheme to PAMs and is developing a guide for manufacturers and auditors.

As these materials may be in intimate contact with a material which will be administered to patients, they should be manufactured in accordance with GMP principles. Typically, PAMs ar...

In this webinar, originally broadcast as part of the Pharmapack Europe show, Robert Schultheis, Founder & Chief Technology Officer, ZebraSci discusses: • Probabilistic vs deterministic CCI Testing • Presentation of the different deterministic CCI testing methods with applications and limitations ...

In this webinar, originally broadcast as a part of Pharmapack Europe 2022, speakers from STERIS will be describing the methodology for transferring the sterilization process of medical or pharma products from one radiation technology to another (e.g. gamma to X-ray).

In this webinar, originally part of Pharmapack Europe 2022, Bernd Garska, Technical Marketing Manager Healthcare EMEA, Covestro AG discusses how until now, drug delivery devices would require tedious sorting with a variety of materials used in various components. Now, with an all-polycarbonate device, mini...

In this webinar, originally broadcast as a part of Pharmapack Europe 2022, Isabelle Jenny, Sustainability Manager, Amcor in collaboration with Healthcare Plastics Recycling Council (HPRC) discusses as consumers awareness and demand continues to grow, switching to sustainable packaging materials and practic...

Join our panel discussion, where out experts will conduct a deep dive through the challenges in drug manufacturing. Key discussion points include: Bottlenecks in skilled workforce and what can be done to overcome this Assessing the challenges in both product and manufacturing quality and identifying...

In this webinar, originally broadcast as part of CPHI NA, Michael Sassano, CEO and Chairman, Somai Pharmaceuticals discusses: • Global Pharmaceutical Cannabis market and the history of recent growth • Current trends in the Medical Cannabis market versus the Canadian and American experience • Herbal M...

In this webinar is originally broadcast as part of CPHI North America, with speakers Robert Bloder, Chief Business Officer, Ascendia Pharma, Chris Senanayake, CEO & CSO, TCG GreenChem, Inc. and John Pennett, Partner-in-Charge of the National Technology and Life Sciences Group, EisnerAmper. The thread line:...

Discuss strategies and methodologies to develop scalable, robust, and cost-effective manufacturing processes for allogeneic cell therapies Showcase how induced pluripotent stem cells (iPSC) are being used as renewable sources of allogeneic cancer therapies Demonstrate the criticality of GMP manufacturing...